Abstract

Mitochondrial DNA (mtDNA)-related diseases often pose a diagnostic challenge and require rigorous clinical and laboratory investigation. Pathogenic variants in the mitochondrial tRNA gene MT-TY, which encodes the tRNATyr, are a rare cause of mitochondrial disease. Here we describe a novel m.5860delTA anticodon variant in the MT-TY gene in a patient who initially presented with features akin to a childhood onset myasthenic syndrome. Using histochemical, immunohistochemical and protein studies we demonstrate that this mutation leads to severe biochemical defects of mitochondrial translation, which is reflected in the early onset and progressive phenotype. This case highlights the clinical overlap between mtDNA-related diseases and other neuromuscular disorders, and demonstrates the potential pitfalls in analysis of next generation sequencing results, given whole exome sequencing of a blood DNA sample failed to make a genetics diagnosis. Muscle biopsy remains an important requirement in the diagnosis of mitochondrial disease and in establishing the pathogenicity of novel mtDNA variants.

Highlights

  • IntroductionMitochondrial DNA (mtDNA) contains 13 genes that encode essential subunits of the oxidative phosphorylationA.Z

  • Mitochondrial DNA contains 13 genes that encode essential subunits of the oxidative phosphorylationA.Z

  • Other neuromuscular disorders, such as myasthenic syndromes can often be mistaken for mitochondrial myopathies [5,6,7] and diagnostic investigation of myasthenia syndromes should consider the possibility of mitochondrial disease

Read more

Summary

Introduction

Mitochondrial DNA (mtDNA) contains 13 genes that encode essential subunits of the oxidative phosphorylationA.Z. Rastelli et al / Neuromuscular Disorders 30 (2020) 661–668 same point mutation may have different phenotypes and identical mitochondrial syndromes can be caused by different genetic variants. This loose genotypephenotype correlation in mtDNA-related disease can lead to diagnostic difficulties. We have identified a novel m.5860delTA variant in the MT-TY gene and confirmed its pathogenicity through detailed phenotyping in conjunction with functional laboratory work. This novel variant is the first dinucleotide deletion in the MT-TY gene, allowing us to directly compare its clinical and biochemical consequences with those of other pathogenic MT-TY gene variants

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.